Tesaro Inc (TSRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TSRO | ELVN | INDV | ||
| Company | Tesaro Inc | Enliven Therapeutics Inc | Indivior Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 74.95 | 57.99 | 35.00 | ||
| High | 74.97 | 58.45 | 35.44 | ||
| Low | 74.94 | 57.23 | 34.50 | ||
| Last | 74.96 | 57.86 | 34.56 | ||
| Change | +0.02 | -0.03 | -0.37 | ||
| Percent Change | +0.03% | -0.05% | -1.06% | ||
| Volume | 1,191,000 | 1,056,400 | 2,094,900 | ||
| 20-Day Average Volume | 2,437,580 | 889,595 | 2,150,175 | ||
| Previous | 74.94 | 57.89 | 34.93 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 74.22 | 59.42 | 37.45 | ||
| 20-Day Raw Stochastic | 92.22% | 25.54% | 4.06% | ||
| 20-Day Relative Strength | 76.34 | 54.94 | 33.50 | ||
| Weighted Alpha | -7.10 | +88.04 | +26.53 | ||
| Today's Opinion | 100% Buy | 80% Buy | 24% Sell | ||
| Yesterday's Opinion | 100% Buy | 80% Buy | 24% Sell | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 64% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.40% since 01/11/19 | -5.16% since 08/25/26 | -3.92% since 08/25/26 | ||
| Low | 74.63 on 01/14/19 | 56.33 on 08/31/26 | 34.33 on 08/31/26 | ||
| High | 74.97 on 01/18/19 | 61.82 on 08/27/26 | 36.21 on 08/26/26 | ||
| 1-Month | |||||
| %Chg | +2.04% since 12/18/18 | +5.56% since 07/31/26 | -13.62% since 07/31/26 | ||
| Low | 72.59 on 12/21/18 | 52.73 on 08/03/26 | 34.33 on 08/31/26 | ||
| High | 75.16 on 12/28/18 | 62.32 on 08/05/26 | 41.18 on 08/03/26 | ||
| 3-Month | |||||
| %Chg | +74.41% since 10/18/18 | +54.25% since 06/01/26 | -0.92% since 06/01/26 | ||
| Low | 23.41 on 11/09/18 | 33.45 on 06/08/26 | 32.41 on 06/02/26 | ||
| High | 75.16 on 12/28/18 | 62.32 on 08/05/26 | 42.81 on 06/26/26 | ||
| 6-Month | |||||
| %Chg | +83.01% since 07/18/18 | +94.88% since 02/27/26 | +5.62% since 02/27/26 | ||
| Low | 23.41 on 11/09/18 | 26.70 on 03/18/26 | 27.68 on 03/24/26 | ||
| High | 75.16 on 12/28/18 | 62.32 on 08/05/26 | 42.81 on 06/26/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,126,323 | 4,241,659 | 4,122,229 | ||
| Shares Outstanding, K | 55,047 | 73,271 | 118,014 | ||
| Annual Sales, $M | 223,330,000 | 0 | 1,239,000,000 | ||
| Annual Net Income, $M | -496,130,000 | -103,690,000 | 210,000,000 | ||
| Last Qtr Sales, $M | 64,400,000 | 0 | 343,000,000 | ||
| Last Qtr Income, $M | -137,090,000 | -32,490,000 | 122,000,000 | ||
| 60-Month Beta | 0.38 | 0.27 | 0.86 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.49 on 11/01/18 | -0.49 on 08/05/26 | 1.15 on 08/03/26 | ||
| Latest Earnings Date | 02/26/19 | 11/11/26 | 10/29/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 9.55 | ||